According to Fortune Business Insights, the global chronic wound care market size was valued at USD 15.27 billion in 2025 and is projected to grow from USD 16.39 billion in 2026 to USD 29.22 billion by 2034, registering a CAGR of 7.50% during the forecast period. The market is being driven by the rising prevalence of chronic wounds, increasing incidence of diabetic ulcers and pressure ulcers, technological advancements in wound management, and growing adoption of advanced wound care products. North America held the leading position with a 37.42% market share in 2025.

What Is the Chronic Wound Care Market?

Chronic wound care refers to the medical products, devices, therapies, and clinical approaches used to manage wounds that fail to heal through the normal healing process. These wounds may result from diabetes, prolonged pressure, venous disorders, or other underlying health conditions.

The major categories of chronic wounds include diabetic ulcers, pressure ulcers, venous leg ulcers, and other wound types. Effective treatment may require advanced dressings, wound care devices, active therapies, infection management, and continuous clinical monitoring.

The growing clinical and economic burden associated with chronic wounds is encouraging healthcare providers and manufacturers to invest in more effective treatment solutions.

Chronic Wound Care Market Size and Forecast

The global chronic wound care market was worth USD 15.27 billion in 2025. It is estimated to reach USD 16.39 billion in 2026 and USD 29.22 billion by 2034, expanding at a CAGR of 7.50% between 2026 and 2034.

The increasing number of patients suffering from chronic wounds is generating sustained demand for wound dressings, devices, and active therapies. At the same time, technological developments are improving the effectiveness and convenience of wound management.

The market's expansion is also supported by increasing patient visits to hospitals and specialized wound care centers following the disruption caused by the COVID-19 pandemic.

Request a Free Sample: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/chronic-wound-care-market-100222 

Key Chronic Wound Care Market Trends

Increasing Adoption of Active Therapies

One of the important trends shaping the chronic wound care market is the increasing application of active therapies. Healthcare companies and research institutions are focusing on bioactive therapies, skin grafts, and other advanced approaches designed to accelerate the wound-healing process.

Research into polymer-based dressings loaded with bioactive agents and biopolymer dressings for diabetic foot ulcers demonstrates the growing focus on advanced treatment approaches.

The introduction of innovative active therapies is expected to increase their adoption and contribute to market growth through 2034.

Growing Demand for Advanced Wound Dressings

Advanced wound dressings are becoming increasingly important because of their efficiency in managing different types of chronic wounds. Products such as foam dressings and other advanced solutions are designed to support wound management while addressing specific clinical requirements.

According to Fortune Business Insights, advanced wound dressings are projected to account for 47.72% of the market in 2026, making them the leading product segment.

Integration of Technology and Artificial Intelligence

Technological advancement is another major factor influencing the market. Companies are developing products and devices that improve wound management, infection prevention, pressure management, and healing outcomes.

Artificial intelligence is also being integrated into chronic wound management. For example, AI-enabled pressure-management systems can use sensors to monitor patient characteristics such as weight, height, and body position and adjust mattress pressure accordingly.

Such technology can support the prevention of pressure ulcers while improving patient monitoring and care efficiency.

Chronic Wound Care Market Growth Drivers

Rising Prevalence of Chronic Wounds

The growing prevalence of diabetic ulcers, pressure ulcers, and other chronic wounds is a primary factor driving demand for wound care products.

Diabetes is particularly important because diabetic patients face an increased risk of developing foot ulcers. Pressure injuries also represent a significant clinical challenge, particularly among patients requiring long-term care.

As the number of patients requiring specialized wound management increases, healthcare providers are expected to increase their use of advanced dressings, wound care devices, and active therapies.

Increasing Healthcare Expenditure

Healthcare spending associated with chronic wounds can be substantial because patients may require prolonged treatment and repeated clinical interventions.

The economic burden of conditions such as venous leg ulcers and pressure ulcers is encouraging healthcare systems to seek treatment options that can improve wound management and potentially reduce the long-term cost of care.

This emphasis on efficient treatment is supporting demand for advanced wound care products.

Technological Innovation in Wound Management

Manufacturers are investing in research and development to introduce advanced wound dressings, devices, infection-prevention solutions, and active therapies.

The launch of products incorporating specialized substrates and infection-prevention technologies demonstrates the industry's emphasis on improving clinical outcomes.

Continued innovation is expected to create additional opportunities for companies operating in the chronic wound care market.

Chronic Wound Care Market Restraints

High Treatment Costs

The high cost of advanced wound dressings, devices, and bioactive products can restrict adoption, particularly in developing and emerging economies.

Complex wounds may require long treatment periods and repeated medical interventions, increasing the financial burden on patients and healthcare systems.

High treatment costs can therefore limit access to advanced wound care solutions in price-sensitive markets.

Inadequate Reimbursement Policies

Inadequate reimbursement for advanced wound care products is another challenge facing the industry.

While developed markets generally benefit from stronger healthcare infrastructure and reimbursement mechanisms, emerging countries may have limited reimbursement coverage. This can make advanced wound care products less accessible and restrict market penetration.

Improved reimbursement policies and greater awareness of chronic wound treatment options could help address this challenge.

Chronic Wound Care Market Segmentation

The chronic wound care market is segmented based on type, product, end user, and geography.

By Type

Based on type, the market is categorized into:

• Diabetic ulcers
• Pressure ulcers
• Venous leg ulcers
• Others

The diabetic ulcers segment is expected to dominate, accounting for 44.06% of the market in 2026. Its leadership is primarily associated with the rising prevalence of diabetes and the increasing occurrence of diabetic foot ulcers.

The pressure ulcers segment is also expected to register significant growth as the number of patients suffering from pressure injuries increases and spending on their treatment rises.

By Product

The market is divided into:

• Advanced wound dressings
• Wound care devices
• Active therapy
• Others

Advanced wound dressings are projected to remain the leading product segment, with a 47.72% share in 2026.

Their dominance is associated with their efficiency and relatively lower cost compared with certain other treatment approaches. Meanwhile, the active therapy segment is expected to record a higher growth rate as healthcare providers increasingly adopt advanced approaches for treating chronic wounds.

By End User

Based on end user, the market is classified into:

• Hospitals & wound care centers
• Homecare settings & others

Hospitals and wound care centers are projected to dominate, representing 69.39% of the market in 2026.

However, homecare settings are expected to experience significant growth as patients increasingly prefer personalized care outside traditional hospital environments.

North America Chronic Wound Care Market

North America dominated the global market in 2025, generating USD 5.69 billion and accounting for 37.42% of global revenue.

The region's leadership is supported by the high prevalence of chronic wounds, significant treatment expenditure, established healthcare infrastructure, and reimbursement policies in the U.S. and Canada.

The U.S. chronic wound care market is projected to reach USD 5.44 billion in 2026. The substantial patient population and demand for advanced wound dressings and treatment technologies are expected to maintain the region's strong position.

Europe Chronic Wound Care Market

Europe generated USD 5.14 billion in 2025, representing 33.44% of the global market.

The regional market is benefiting from an increasing patient population with chronic wounds and rising expenditure on diabetic ulcers, pressure ulcers, venous ulcers, and other conditions.

Germany and the U.K. represent important markets within the region. The Germany market is projected to reach USD 1.15 billion in 2026, while the U.K. market is projected to reach USD 0.49 billion.

Asia Pacific Chronic Wound Care Market

Asia Pacific generated USD 3.41 billion in 2025 and accounted for 22.32% of global market revenue.

The region offers significant growth opportunities because of rising healthcare expenditure, increasing awareness of wound treatment options, and growing participation by international companies.

The Japan chronic wound care market is projected to reach USD 0.87 billion in 2026, while China's market is projected to reach USD 1.83 billion. India's market is projected to reach USD 0.32 billion in the same year.

Increasing awareness and improvements in healthcare access are expected to support future market development across Asia Pacific.

Latin America and Middle East & Africa Market Outlook

Latin America and the Middle East & Africa currently represent comparatively smaller portions of the global chronic wound care market.

Factors such as limited awareness, lower per-capita income, and inadequate reimbursement policies can restrict the adoption of advanced wound care products.

Nevertheless, the increasing burden of chronic diseases and the need for effective wound management could create opportunities for manufacturers as healthcare infrastructure and access to treatment improve.

Competitive Landscape of the Chronic Wound Care Market

The global market features several established medical device and wound care companies with broad product portfolios and extensive distribution networks.

Key companies profiled by Fortune Business Insights include:

• Smith & Nephew
• Mölnlycke Health Care AB
• 3M
• ConvaTec Group PLC
• Tissue Regenix
• B. Braun Melsungen AG
• Integra LifeSciences Corporation
• Coloplast Corp
• Cardinal Health
• MiMedx

Product launches, acquisitions, strategic partnerships, and geographic expansion remain important competitive strategies.

For example, ConvaTec Group launched ConvaFoam in the U.S. in January 2023, while Integra LifeSciences acquired ACell to strengthen its complex wound management capabilities.

Recent Industry Developments

The market has witnessed several developments aimed at strengthening product portfolios and expanding access to advanced wound care.

In June 2023, JeNaCell, an Evonik company, introduced epicite balance for chronic wounds in Germany. In January 2023, MiMedx entered into an exclusive distribution agreement with Gunze Medical Limited to sell Epifix in Japan.

Other developments include Medela LLC's partnership with MedPro to expand access to wound therapy systems and ConvaTec Group's acquisition of Triad Life Sciences to enter the wound biologics segment.

These developments demonstrate the industry's focus on product innovation, strategic partnerships, acquisitions, and geographic expansion.

Future Outlook for the Chronic Wound Care Market

The outlook for the chronic wound care market remains positive as healthcare systems face a growing burden of hard-to-heal wounds.

The increasing prevalence of diabetes and pressure injuries is expected to sustain demand for wound management products. At the same time, innovation in advanced dressings, wound care devices, active therapies, and AI-enabled solutions is likely to create new opportunities.

The shift toward home-based and personalized care may also influence product development and distribution strategies. However, companies will need to address treatment affordability and reimbursement challenges to expand access in emerging markets.

Overall, the global chronic wound care market is expected to grow from USD 16.39 billion in 2026 to USD 29.22 billion by 2034 at a CAGR of 7.50%.

Key Takeaways

• The global chronic wound care market was valued at USD 15.27 billion in 2025.
• The market is projected to reach USD 29.22 billion by 2034.
• The market is expected to grow at a CAGR of 7.50% from 2026 to 2034.
• North America held the largest market share of 37.42% in 2025.
• Diabetic ulcers are projected to remain the leading type segment.
• Advanced wound dressings are expected to dominate the product segment.
• Hospitals and wound care centers are projected to remain the leading end-user segment.
• Active therapies and AI-enabled wound management represent important areas of innovation.
• High treatment costs and inadequate reimbursement remain key challenges.
• Product launches, acquisitions, and strategic partnerships are shaping the competitive landscape.

Read Report Insights: https://www.fortunebusinessinsights.com/industry-reports/chronic-wound-care-market-100222

Frequently Asked Questions About the Chronic Wound Care Market

1. How big is the chronic wound care market in 2026?

According to Fortune Business Insights, the global chronic wound care market is projected to reach USD 16.39 billion in 2026. The market is expected to expand to USD 29.22 billion by 2034 at a CAGR of 7.50% during 2026–2034.

2. What is the CAGR of the chronic wound care market?

The global chronic wound care market is projected to grow at a CAGR of 7.50% from 2026 to 2034. Increasing prevalence of chronic wounds, technological advancements, and growing adoption of advanced wound care products are supporting this growth.

3. Which segment dominates the chronic wound care market?

The diabetic ulcers segment is projected to be the leading type segment, accounting for 44.06% of the market in 2026. By product, advanced wound dressings are expected to lead with a 47.72% share, while hospitals and wound care centers are projected to account for 69.39% of the market by end user.

4. What are the latest trends in the chronic wound care market?

Key trends include increasing adoption of active therapies, development of advanced wound dressings, integration of artificial intelligence into wound management, technological innovation in wound care devices, and a growing shift toward personalized and home-based care.

5. Who are the key players in the chronic wound care market?

Major companies profiled in the market include Smith & Nephew, Mölnlycke Health Care AB, 3M, ConvaTec Group PLC, Tissue Regenix, B. Braun Melsungen AG, Integra LifeSciences Corporation, Coloplast Corp, Cardinal Health, and MiMedx.

Explore Japan’s Market Opportunities - Latest - chronic wound care market- Insights